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Abstract
Autophagy degrades pathogens in vitro. The autophagy gene Atg5 has been reported to be required for IFN-c-dependent
host protection in vivo. However, these protective effects occur independently of autophagosome formation. Thus, the in
vivo role of classic autophagy in protection conferred by adaptive immunity and how adaptive immunity triggers
autophagy are incompletely understood. Employing biochemical, genetic and morphological studies, we found that CD40
upregulates the autophagy molecule Beclin 1 in microglia and triggers killing of Toxoplasma gondii dependent on the
autophagy machinery. Infected CD40
2/2 mice failed to upregulate Beclin 1 in microglia/macrophages in vivo. Autophagy-
deficient Beclin 1
+/2 mice, mice with deficiency of the autophagy protein Atg7 targeted to microglia/macrophages as well
as CD40
2/2 mice exhibited impaired killing of T. gondii and were susceptible to cerebral and ocular toxoplasmosis.
Susceptibility to toxoplasmosis occurred despite upregulation of IFN-c, TNF-a and NOS2, preservation of IFN-c-induced
microglia/macrophage anti-T. gondii activity and the generation of anti-T. gondii T cell immunity. CD40 upregulated Beclin 1
and triggered killing of T. gondii by decreasing protein levels of p21, a molecule that degrades Beclin 1. These studies
identified CD40-p21-Beclin 1 as a pathway by which adaptive immunity stimulates autophagy. In addition, they support that
autophagy is a mechanism through which CD40-dependent immunity mediates in vivo protection and that the CD40-
autophagic machinery is needed for host resistance despite IFN-c.
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Introduction
The lysosomal system is an effector of microbial degradation.
Unfortunately, many pathogens including the intracellular
protozoan Toxoplasma gondii have developed various strategies to
avoid lysosomal degradation. Autophagy isa mechanism that can
re-route pathogens to lysosomes. Autophagy is a process where
an isolation membrane encircles portions of cytosol and
organelles leading to the formation of autophagosomes [1,2].
Fusion between autophagosomes and endosomes-lysosomes
culminates in the formation of autolysosomes and degradation
of their contents. Autophagy can mediate in vitro anti-microbial
activity against various pathogens [3,4,5,6,7]. In the case of T.
gondii infection, the CD40 – CD154 pathway triggers killing of
the parasite within macrophages that is dependent on the
autophagy pathway [6,8]. CD40 is a member of the TNF
receptor superfamily expressed on antigen presenting cells as well
as on some non-hematopoietic cells, while CD154 (CD40 ligand)
is expressed primarily on activated CD4
+ T cells. The interaction
between T. gondii-reactive T cells and infected macrophages
results in CD40-dependent killing of the parasite through the
autophagy pathway [6].
Innate immunity can activate autophagy to mediate host
protection in vivo. Autophagy protects Drosophila against Listeria
monocytogenes and Vesicular stomatitis virus [9,10]. In the case of
Herpes simplex virus 1 (HSV-1), the virus prevents autophagy by
producing the neurovirulence factor ICP34.5 that binds and
blocks the effect of the autophagy protein Beclin 1 [11]. A strain of
HSV-1 deficient in ICP34.5 does not cause encephalitis in wild
type mice but causes disease in mice deficient in PKR, a signaling
molecule linked to autophagy [11]. Similarly, in a model of
Salmonella infection in Caenorhabditis elegans and Dictyostelium
discoideum, autophagy gene inactivation results in increased
bacterial replication and decreased animal lifespan [12].
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14472The autophagy gene ATG5 mediates autophagosome-indepen-
dent host protection. Studies in mice deficient in ATG5 in
phagocytes revealed that this autophagy gene was required for
IFN-c-mediated in vivo host protection likely because ATG5 was
required for the induction of IFN-c-dependent anti-microbial
activity in macrophages [13]. ATG5 was required for recruitment
of the Immunity- Related GTPase (IRG) Irga6 to the para-
sitophorous vacuole, the damage to this structure and clearance of
the parasite [13]. This process occurred independently of classical
autophagosome formation. In addition, mice with inactivation of
ATG5 in dendritic cells revealed that this gene promoted the
induction of a Th1 response and protection against HSV-1 [14].
The role of ATG5 in dendritic cells was to enhance MHC II
processing of phagocytosed antigens that contain TLR agonists
[14]. Processing of antigens for MHC II did not appear to be
dependent on canonical autophagy [14]. These studies indicate
that ATG5 regulates IFN-c-dependent host protection and it does
so through a manner that is does not rely on classical autophagy.
Thus, the in vivo role of autophagy in mediating protection
conferred by adaptive immunity is still not completely understood.
In addition, it is unclear how adaptive immunity activates
autophagy.
T. gondii can cause disease that manifests as cerebral and/or
ocular toxoplasmosis. IFN-c, TNF-a and their downstream
effector molecule NOS2 are considered the mediators of resistance
against ocular and cerebral toxoplasmosis [15,16,17,18,19,20]. We
report herein that despite the induction of pathogen-reactive T
cells, IFN-c, TNF-a, NOS2, and the preservation of IFN-c-
induced antimicrobial activity in microglia/macrophages, adap-
tive immunity still required the autophagic pathway to confer in
vivo protection against cerebral and ocular toxoplasmosis. CD40
upregulates Beclin 1, triggers autophagy and killing of T. gondii in
microglia independently of IFN-c, nitric oxide and Irga6. This
pathway is required for host protection since mice deficient in
Beclin 1, mice with defective expression of Atg7 in microglia/
macrophages and CD40
2/2 mice exhibit impaired autophagy
protein-dependent killing of T. gondii and are susceptible to
cerebral and ocular toxoplasmosis despite induction of T. gondii-
specific T cell response, upregulation of IFN-c, TNF-a and NOS2
and unimpaired IFN-c-induced anti-microbial activity in microg-
lia/macrophages. We also identified a pathway whereby adaptive
immunity enhances autophagy. CD40 down-regulates p21 leading
to increased levels of Beclin 1 and enhanced autophagy.
Results
CD40
2/2 mice are susceptible to ocular toxoplasmosis
and toxoplasmic encephalitis despite upregulation of
IFN-c, TNF-a and NOS2
B6 and CD40
2/2 mice were infected with T. gondii. As shown in
Figure 1A, CD40
2/2 died during the chronic phase of infection
between weeks 4 to 6 while B6 mice survived at least 11 weeks
(p,0.001). We conducted histopathologic studies of the eye and
brain. The histological features of the choroid and retina from
uninfected B6 and CD40
2/2 mice were similar. At 4 weeks post-
infection, infected B6 mice revealed mild histopathologic changes
in the retina and choroid (Figure 1B). In contrast, CD40
2/2 mice
revealed more pronounced histopathology (p,0.01) that included
distortion of the retinal architecture, hypertrophy of retinal
pigmented epithelial cells, invasion of the retina by these cells,
inflammatory infiltrates as well as occasional tissue cysts
(Figure 1C–E). Next, we examined the parasite load to determine
if worse histopathology in CD40
2/2 mice was linked to inability to
control the parasite. Compared to B6 mice, CD40
2/2 mice
exhibited a significantly higher parasite load in the eye as assessed
by quantification of parasite DNA (Figure 1F) (p,0.02).
Histopathologic studies of the brain at 4 weeks post-infection
showed that CD40
2/2 mice had more extensive parenchymal
inflammatory foci, perivascular cuffing and more numerous tissue
cysts than infected B6 mice (Figure 1G, H). Histopathologic
changes were more pronounced in CD40
2/2 mice than in B6
mice (p,0.01). A significantly higher parasite load in the brain as
assessed by the number of tissue cysts accompanied worsened
histopathology in CD40
2/2 mice (Figure 1I) (p,0.001). CD40
2/2
mice also exhibited increased parasite load and more pronounced
histopathology at 2 weeks post-infection (not shown). Thus, CD40
is critical for control of ocular and cerebral toxoplasmosis. These
results are similar to those obtained with CD154
2/2 mice [21]
and indicate that in contrast to studies with Mycobacterium
tuberculosis [22], both components of the CD40 – CD154 pathway
are critical for resistance against the chronic phase of T. gondii
infection.
Next, we examined whether susceptibility to toxoplasmosis in
CD40
2/2 mice could be explained by impaired expression of
IFN-c, TNF-a and NOS2. Compared to uninfected mice, T. gondii
infected animals exhibited at least a 2-log increase in mRNA levels
of these genes (not shown) and eyes and brains from both infected
CD40
2/2 and infected B6 mice exhibited upregulation of mRNA
of these genes at 2 and 4 weeks post-infection (Figure 2A and not
shown). Immunohistochemical studies of the brain and immuno-
blot of brain lysates at 4 weeks post-infection revealed protein
expression of NOS2 and TNF-a in both CD40
2/2 and control
mice (Figure 2B and 2C). Thus, CD40
2/2 mice are susceptible to
ocular and cerebral toxoplasmosis despite upregulation of key
mediators of host protection: IFN-c, TNF-a and NOS2.
CD40 upregulates autophagy proteins and stimulates
autophagy
Microglia are considered central mediators of resistance against
T. gondii in neural tissue [16]. Microglia were incubated with a
stimulatory anti-CD40 or control mAb. Primary brain or retinal
microglia treated with a stimulatory anti-CD40 mAb exhibited a
significant lower parasite load than control microglia (p,0.02)
(Figure 3A). Similar results were obtained with 2 mouse microglia
cell lines (BV-2 and N9) or by treating cells with mouse CD154
(not shown). Anti-T. gondii activity induced by CD40 was not
impaired by a neutralizing anti-IFN-c mAb, or NMA, an inhibitor
of NOS2 (p.0.5) (Figure S1A and S1B). In contrast, anti-IFN-c
mAb or NMA blocked the anti-T. gondii activity induced by IFN-
c/TNF-a (p,0.001). The autophagy pathway was required for
CD40-induced anti-T. gondii activity in microglia because CD40
stimulation caused recruitment of the autophagy marker LC3
around the parasite (Figure 3B) and silencing of Beclin 1 using
siRNA ablated CD40-induced anti-T. gondii activity (p,0.01)
(Figure 3C). In contrast, silencing of Beclin 1 had no effect on IFN-
c/TNF-a induced anti-T. gondii activity. The role of the autophagy
pathway was also studied in primary microglia and macrophages.
Treatment of microglia with the autophagy inhibitor 3-methyl
adenine (3-MA) inhibited toxoplasmacidal activity induced by
CD40 stimulation (p,0.01) (Figure S2A). Silencing of Atg5
prevented CD40 stimulation from decreasing the parasite load
in primary macrophages and microglia (p,0.01) (Figures S2B and
S2C). Similarly, silencing of Atg5 in BV-2 cells ablated
toxoplasmacidal activity induced by CD40 (p,0.01) (Figure S2D).
Atg5 mediates anti-T. gondii activity in IFN-c-activated
macrophages independent of autophagosome formation [13].
IFN-c induces killing of type II strains of the parasite through
Atg5-dependent recruitment of Irga6 to the membrane of the
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mechanism of anti-microbial activity triggered by CD40 is distinct
from that utilized by IFN-c. Figure S3A shows that CD40 induced
anti-microbial activity against not only a type I strain of T. gondii
(RH) but also against a type II strain (ME49). Knockdown of
Beclin 1 ablated the anti-T. gondii activity against a type II strain of
the parasite induced by CD40 but had no effect on anti-T. gondii
activity mediated by IFN-c (Figure S3B). Importantly, knockdown
of Irga6 did not impair CD40-induced killing of T. gondii while it
inhibited the effect of IFN-c (Figure S3C). Taken together, these
studies indicate that CD40 induces entrapment of T. gondii by
autophagosomes and triggers anti-T. gondii activity in retinal and
brain microglia through the autophagy pathway, a process that is
distinct from that utilized by IFN-c since CD40 not only acts
Figure 1. CD40
2/2 mice are susceptible to the chronic phase of T. gondii infection. B6 and CD40
2/2 mice were infected with tissue cysts of
the ME49 strain of T. gondii. A, Survival was monitored daily. Data shown are from groups containing 8 mice. B–I, B6 and CD40
2/2 mice were
euthanized at 4 weeks post-infection. B, Eyes from infected B6 mice revealed mild histopathology. C–E, Eyes from infected CD40
2/2 mice revealed
disruption of retinal architecture, more prominent inflammation (C), invasion of the retina by retinal pigmented epithelial cells (D) and occasional
tissue cysts (E). Periodic Acid Schiff-Hematoxylin (PASH); B, C X200; D X400; E X1,000. F, CD40
2/2 mice exhibit higher parasite load in the eye than B6
mice. DNA was isolated from eyes. Levels of the T. gondii B1 gene were examined using quantitative PCR. Each group contained 5 mice. Results are
shown as the mean 6 SEM. G, Brains from infected B6 mice showed slight inflammation. H, Brains from infected CD40
2/2 mice show prominent areas
of inflammation (arrow) and numerous tissue cysts (arrow head). PASH X100. I, CD40
2/2 mice exhibit higher numbers of tissue cysts in the brain than
B6 mice. Each group contained 5 mice. Results are representative of 4 independent experiments. *#0.05; ***p#0.001.
doi:10.1371/journal.pone.0014472.g001
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2/2 mice exhibit upregulation of IFN-c, TNF-a and NOS2 in the eye and brain. B6 and CD40
2/2 mice
were euthanized 4 weeks after infection with tissue cysts of the ME49 strain of T. gondii. A, Levels of IFN-c, TNF-a and NOS2 mRNA in eyes and brains
were examined using quantitative PCR and normalized against the levels of 18s rRNA. Each group contained 5 mice. Results are shown as the mean 6
SEM. B, Brains were subjected to immunohistochemistry for NOS2 (X100) and TNF-a (X200). TNF-a was detected not only in the brain parenchyma but
also within blood vessel walls in both B6 and CD40
2/2 mice (inset). C, Brains were lysed and subjected to immunoblot for NOS2, TNF-a and actin.
Each lane represents one mouse. Results are representative of 3 to 4 independent experiments.
doi:10.1371/journal.pone.0014472.g002
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nitric oxide. Moreover, CD40 but not IFN-c requires Beclin 1, an
autophagy protein that controls autophagosome formation [23].
The level of Beclin 1 expression has been linked to autophagic
activity [24,25]. We examined whether CD40 modulates Beclin 1
expression. As shown in Figure 4A, CD40 stimulation caused a
rapid increase in Beclin 1 protein expression in primary microglia
(2.8-fold increase on average; n=4). CD40 stimulation also caused
an apparently less pronounced upregulation of the Atg5 expression
(average 1.7-fold) but did not appear to affect expression of Atg7
(Figure 4A). We examined whether CD40 affects the in vivo levels
of Beclin 1 during T. gondii infection. While we did not detect
differences in Beclin 1 protein expression between brain microglia
from uninfected B6 and CD40
2/2 mice, Beclin 1 expression in
microglia/macrophages from T. gondii-infected B6 mice was
higher than in microglia/macrophages from infected CD40
2/2
mice (Figure 4B).
We determined if CD40 not only increased expression of
autophagy protein but also enhanced basal levels of autophagy.
BV-2 cells were transfected with LC3-EGFP and were incubated
with or without anti-CD40 mAb. CD40 stimulation increased the
percentage of microglia with LC3
+ punctae (Figure 4C, D). An
increase in these structures could be due to increased autophago-
some formation or decreased degradation. Microglia were treated
with bafilomycin A1, an inhibitor of vacuolar ATPase, which
prevents autophagosome degradation [26]. CD40 stimulation still
upregulated LC3
+ punctae when autophagosome degradation was
prevented. CD40 stimulated autophagy through Beclin 1 because
knock-down of this autophagy protein inhibited upregulation of
LC3
+ punctae (Figure 4E) (p,0.001). Together, CD40 increases
expression of Beclin 1 and Atg5 in microglia and enhances
autophagy.
Next, we tested whether changes in the level of autophagy
protein expression affect toxoplasmacidal activity induced by
CD40. We centered on Beclin 1 given that levels of expression of
this protein can affect autophagy. BV-2 cells were transfected with
a Beclin 1-encoding plasmid or with empty plasmid (Figure 4F). A
suboptimal concentration of anti-CD40 mAb (1 mg/ml) did not
affect Beclin 1 expression and did not induce anti-T. gondii activity
in BV-2 cells transfected with the empty plasmid. In contrast,
Beclin 1-transfected BV-2 cells exhibited on average a 2.4-fold
increase in Beclin 1 protein expression that was accompanied by
anti-T. gondii activity even if stimulated with 1 mg/ml of anti-CD40
mAb (Figure 4F). Conversely, BV-2 cells transfected with a
suboptimal concentration of Beclin 1 siRNA exhibited on average
a 53% reduction in Beclin 1 protein levels and ablated CD40-
induced anti-T. gondii activity despite treatment with a fully
activating dose of anti-CD40 mAb (10 mg/ml) (Figure 4G). Thus,
Figure 3. Autophagy mediates anti-T. gondii activity induced by CD40 in microglia. A, Primary retinal and brain microglia obtained from B6
mice were incubated with a stimulatory anti-CD40 or control mAb, or with IFN-c/TNF-a followed by infection with tachyzoites of RH T. gondii. The
numbers of tachyzoites per 100 microglia were determined at 18 h post-infection. B, BV-2 cells were transfected with LC3-EGFP followed by
incubation with anti-CD40 or control mAb. Cells were infected with RFP-T. gondii. Cells were examined at 5 h to determine the percentages of cells
where LC3 accumulated around the parasites (arrow head). C, BV-2 cells were transfected with control siRNA or siRNA against Beclin 1. Protein
expression of Beclin 1 and actin were examined by immunoblot. BV-2 cells transfected with control siRNA or siRNA against Beclin 1 were incubated
with a stimulatory anti-CD40 mAb, control mAb or IFN-c/TNF-a followed by RH T. gondii infection. Results are representative of 3 independent
experiments. *#0.05; **p#0.01.
doi:10.1371/journal.pone.0014472.g003
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PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e14472Figure 4. CD40 upregulates autophagy protein expression and leads to increased autophagy. A, Primary brain microglia from B6 mice
were incubated with anti-CD40 mAb or control mAb. Beclin 1, Atg5 and Atg7 protein expression were normalized against actin. B, Beclin 1 and actin
protein expression in purified brain microglia from uninfected B6 and CD40
2/2 mice or purified brain microglia/macrophages from B6 or CD40
2/2
mice at 4 weeks post-infection. Each lane represents a pool of 2 mice. C, D, BV-2 cells transfected with LC3-EGFP were incubated with anti-CD40 mAb
or control mAb in the presence or absence of bafilomycin A1 (BafA1). E, BV-2 cells were transfected with control or Beclin 1 siRNA. After 2 days, cells
were transfected with LC3-EGFP followed by incubation with anti-CD40 or control mAb. F, BV-2 cells were transfected with Beclin 1-encoding or
empty plasmids. Expression of Beclin 1 and actin were examined by immunoblot. Cells were incubated with anti-CD40 mAb (1 or 10 mg/ml) or control
mAb followed by infection with tachyzoites of RH T. gondii. G, BV-2 cells transfected with a suboptimal concentration of Beclin 1 siRNA or control
were incubated with anti-CD40 mAb (10 mg/ml) or control mAb followed by RH T. gondii infection. Results are representative of 3 to 4 independent
experiments. **p#0.01; ***p#0.001.
doi:10.1371/journal.pone.0014472.g004
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induced anti-T. gondii activity.
CD40 stimulation diminishes p21 expression leading to
Beclin 1 upregulation
p21 has been reported to decrease Beclin 1 expression through
protein degradation [27]. CD40 upregulates Beclin 1 without
affecting Beclin 1 mRNA levels as assessed by real time PCR
(Figure S4). Thus, we examined the role of p21 in Beclin 1
upregulation caused by CD40. CD40 stimulation of primary
microglia and BV-2 cells caused a rapid decrease in p21 levels
(Figure 5A). In addition, knockdown of p21 by transfection with
siRNA induced Beclin 1 upregulation in BV-2 cells incubated with
a sub-optimal concentration of anti-CD40 mAb (Figure 5B). In
contrast, p21 overexpression by transfection with a p21-encoding
plasmid prevented CD40 from increasing Beclin 1 levels
Figure 5. CD40 downregulates p21, increases Beclin 1 expression and autophagic killing of T. gondii. A, Primary brain microglia from B6
mice were incubated with anti-CD40 mAb or control mAb for 1 h followed by assessment of p21 and actin expression. B, BV-2 cells were transfected
with control or p21 siRNA. Cells were incubated with a suboptimal concentration of anti-CD40 (1 mg/ml) or control mAb and followed by assessment
of Beclin 1 expression. In addition, cells were challenged with RH T. gondii and the numbers of tachyzoites per 100 microglia were determined. C, BV-2
cells were transfected with p21-encoding or empty plasmids. Cells were incubated with an optimal concentration of anti-CD40 (10 mg/ml) or control
mAb and followed by assessment of Beclin 1 expression. Cells were challenged with RH T. gondii and the numbers of tachyzoites per 100 microglia
were determined. Results are shown as the mean 6 SEM and are representative of 3 independent experiments. D, Proposed model of the role of p21
in modulation of Beclin 1 expression and activation of T. gondii killing induced by CD40. We previously reported that CD40 induces autophagy and
killing of T. gondii through the adaptor protein TRAF6 [6,8]. This process would be dependent on down-regulation of p21 that would result in
increased levels of Beclin 1 and enhanced autophagy. **p#0.01; ***p#0.001.
doi:10.1371/journal.pone.0014472.g005
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because knockdown of p21 promoted anti-T. gondii activity in
microglia stimulated with a suboptimal concentration of anti-
CD40 mAb (Figure 5B) while overexpression of p21 inhibited anti-
T. gondii activity induced by CD40 (Figure 5C) (p,0.004). These
results indicate that p21 regulates Beclin 1 expression and
autophagy protein-dependent killing of T. gondii in CD40-
stimulated microglia (Figure 5D).
Autophagy-deficient mice are susceptible to ocular
toxoplasmosis and toxoplasmic encephalitis
Our in vitro studies indicate that the levels of Beclin 1 modulate
killing of T. gondii. Based on these findings, we hypothesized that
mice with a partial defect in Beclin 1 would exhibit impaired
killing of T. gondii and susceptibility to ocular and cerebral
toxoplasmosis. We used mice with heterozygous deletion of Beclin
1( Becn1
+/2 mice) to begin to test the in vivo relevance of the
autophagic pathway in protection against cerebral and ocular
toxoplasmosis. Becn1
+/2 mice exhibit diminished Beclin 1 protein
levels and reduced autophagy in vivo [24]. Becn1
+/2 mice infected
with T. gondii exhibited decreased survival compared to littermate
controls (Becn1
+/+) (Figure 6A) (p,0.001). Moreover, infected
Becn1
+/2 mice exhibited higher parasite loads in the brain and eye
(Figure 6B) (p,0.01). Similar to CD40
2/2 animals, Becn1
+/2 mice
exhibited more pronounced retinal histopathology (p,0.01) that
included distortion of the retinal architecture, hypertrophy of
retinal pigmented epithelial cells, retinal invasion by these cells and
inflammatory infiltrates (Figure 6C–E). In the brain, Becn1
+/2
mice had more extensive parenchymal inflammatory foci,
perivascular cuffing as well as more numerous tissue cysts than
control mice (Figure 6F–G) (p,0.01). This increased susceptibility
to toxoplasmosis was not explained by diminished expression of
IFN-c, NOS2 and TNF-a in the brain and eye (Figure 6H). Mice
with Atg5
2/2 hematopoietic cells exhibit defects in T cell
homeostasis [28]. However, Becn1
+/2 mice have a partial defect
in Beclin 1 expression. Indeed, the phenotypic composition of
lymphoid tissue in these mice as well as in CD40
2/2 mice was
similar to that of control mice (Figure S5A). Moreover, these
groups of mice exhibited similar percentages of T. gondii-reactive
IFN-c- or IL-4-producing CD4
+ and CD8
+ T cells as well as
equivalent in vitro secretion of IFN-c after stimulation with T. gondii
lysate antigen (TLA) (Figure S5B and S5C). Next, we studied
microglial anti-microbial activity. Microglia from Becn1
+/2 mice
had diminished Beclin 1 protein levels compared to control mice
(Figure 6I). In marked contrast to the cytokine studies, microglia
from Becn1
+/2 mice had a defect in killing of T. gondii induced by
CD40 but not in anti-T. gondii activity triggered by IFN-c/TNF-a
(Figure 6I). This defect occurred despite normal expression of
CD40 on microglia from Becn1
+/2 mice (cMFI: Control =
103610; Becn1
+/2 =112615). To further confirm that Becn1
+/2
mice exhibit defective autophagic killing of T. gondii, macrophages
from controls and Becn1
+/2 mice were incubated with rapamycin,
an agent that induces anti-T. gondii activity via autophagy [6].
Macrophages from Becn1
+/2 mice exhibited impaired killing
induced by rapamycin (Figure 6I). Thus, in spite of upregulation
of IFN-c, TNF-a and NOS2, and the development of T cell-
mediated immunity against T. gondii, mice with defective
autophagy and with impaired autophagy protein-dependent killing
of the parasite are susceptible to toxoplasmosis.
To further evaluate the role of autophagy for in vivo control of T.
gondii in the brain and eye, we conducted experiments using mice
where another autophagy gene, ATG7, was inactivated in
macrophages/microglia. ATG7 was inactivated in myelomonocyt-
ic cells by breeding of ATG7
flox/flox mice [29] with mice that express
the Cre recombinase from endogenous lysozyme M locus (Lyz-
Cre). Indeed, microglia and macrophages from ATG7
flox/flox-Lyz-Cre
mice had impaired expression of Atg7 (Figure 7A and not shown).
Moreover, microglia as well as macrophages from these mice
exhibited defective killing of T. gondii induced by CD40 but
unimpaired parasite killing in response to IFN-c/TNF-a
(Figure 7A). Compared to control mice (ATG7
flox/flox), ATG7
flox/flox-
Lyz-Cre mice infected with T. gondii were unable to control the
parasite in the brain and eye (Figure 7B) (p,0.01) and exhibited
more prominent histopathology in these organs (Figure 7C–F)
(p,0.01). Similar to the studies with Becn1
+/2 mice, ATG7
flox/flox-
Lyz-Cre mice were susceptible to toxoplasmosis despite upregulation
ofIFN-c,TNF-a and NOS2 mRNA (Figure 7G)and thegeneration
of T. gondii-specific T cell response (Figure 7H). Thus, mice with
defective expression of Atg7 targeted to microglia/macrophages
and impaired killing of T. gondii exhibit defective in vivo control of T.
gondii in neural tissue.
Discussion
The cascades by which adaptive immunity activates autophagic
killing of an intracellular pathogen and the in vivo role of autophagy
in protection conferred by adaptive immunity are incompletely
understood. We report that CD40 rapidly diminishes the levels of
p21, a protein that degrades Beclin 1 [27]. As a result, CD40 causes
upregulation of this autophagy protein and stimulates killing of T.
gondiiinmicroglia dependent on the autophagy pathway. Moreover,
mice with diminished expression of Beclin 1 and mice with
inactivation of Atg7 in microglia/macrophages are susceptible to
cerebral and ocular toxoplasmosis despite upregulation of IFN-c,
TNF-a and NOS2 as well as the induction of T cell-mediated
immunity. Susceptibility to the chronicphase of T. gondiiinfectionin
these mice occurred in the setting of defective autophagy pathway-
dependent killing of the parasite while IFN-c-induced killing of the
parasite was unimpaired in these mice. These results contrast the
report of autophagosome-independent in vivo protection conferred
by Atg5, where Atg5 expression in phagocytic cells was required for
IFN-c-mediated killing of the parasite [13]. The findings reported
herein strongly support the notion that adaptive immunity utilizes
autophagy to confer resistance against an intracellular pathogen
because: i) CD40 induced entrapment of the parasite by an LC3
+
structure; ii) Beclin 1, Atg5 and Atg7 were required for killing of T.
gondii within CD40-activated microglia and macrophages; iii)
Deficiency of two autophagy proteins, Beclin 1 and Atg7, led to
susceptibility to toxoplasmosis while leaving unaffected IFN-c-
induced anti-parasite activity and the induction of an IFN-c-
mediated immune response.
One study reported that autophagosomes surround T. gondii in
primed macrophages [7,13]. This event followed the disruption of
the parasitophorous vacuole membrane raising the possibility that
formation of autophagosomes was a response to the presence of
disrupted structures within host cells [7,13]. However, recent work
in macrophages did not find evidence of autophagosome formation
around the parasite in IFN-c-activated cells [13]. In addition,
studies in astrocytes including work using live-cell imaging revealed
that IFN-c induced killing of T. gondii without localization of LC3 to
the parasitophorous vacuole [30,31]. Interestingly, while Atg5 is
required in killing of the parasite in IFN-c-activated cells, this effect
occurs in association with recruitment of IRG to the parasitophor-
ous vacuole membrane rather than autophagic entrapment of the
parasite [13,32]. IRG disrupt the parasitophorous vacuole mem-
brane indicating that the anti-T. gondii effect of Atg5 in IFN-c-
activated cells is likely dependent on IRG loading onto the
parasitophorous vacuole rather that classical autophagy [13]. Our
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distinction to IFN-c, CD40 induces toxoplasmacidal activity
independently of Irga6 as well as Irgm1 and Irgm3 [33].
Importantly, deficiency of Beclin 1 or Atg7 blocked CD40-induced
killing of T. gondii while leaving unaffected killing induced by IFN-c.
The different mechanisms used by CD40 and IFN-c to kill T. gondii
likely explain the cooperation observed between CD40 and IFN-c
to promote control of the parasite both in vitro [34,35] as well as in
vivo (this study). Indeed, while IFN-c, TNF-a and NOS2 are key for
resistance against chronic toxoplasmosis, we report that the
Figure 6. Autophagy-deficient mice are susceptible to cerebral and ocular toxoplasmosis. Becn1
+/2 and littermate control mice (B6) were
infected with ME49 T. gondii. A, Survival was monitored daily. Data shown are from groups containing 8 mice. B, Mice (5 mice per group) were
euthanized at 4 weeks post-infection. DNA was isolated from eyes and the levels of the T. gondii B1 gene were examined using real time quantitative
PCR. Tissue cysts were counted in brain homogenates. C, Eyes from infected control mice revealed mild histopathology. D, E, Eyes from infected
Becn1
+/2 mice revealed disruption of retinal architecture, more prominent inflammation and invasion of the retina by retinal pigmented epithelial
cells (E). PASH; X200. F, Brains from infected control mice showed slight inflammation. G, Brains from infected Becn1
+/2 mice show prominent areas of
inflammation (arrow) and frequent tissue cysts (arrow head). PASH X100. H, Levels of IFN-c, TNF-a and NOS2 mRNA in eyes and brains were examined
using real time quantitative PCR and normalized against the levels of 18s rRNA. Each group contained 5 mice. I, Beclin 1 and actin protein expression
in primary microglia from control and Becn1
+/2 mice. Primary brain microglia from control and Becn1
+/2 mice and were incubated with anti-CD40 or
control mAb, or with IFN-c/TNF-a followed by infection with tachyzoites of RH T. gondii. Primary bone marrow derived macrophages were obtained
from control and Becn1
+/2 mice and were incubated with or without rapamycin (1 mM) 2 h after infection with tachyzoites of RH T. gondii. Results are
shown as the mean 6 SEM and are representative of 3 independent experiments. **p#0.01.
doi:10.1371/journal.pone.0014472.g006
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ocular and cerebral toxoplasmosis since CD40 as well as the
autophagy proteins Beclin 1 and Atg7 are required for protection
against the disease.
The autophagic machinery can enhance presentation of certain
antigens [14,36] and can promote the generation of a Th1
response [14,37]. Our studies indicate that a T cell response
against T. gondii can develop in mice with defective autophagy
Figure 7. Mice deficient in autophagy in macrophages/microglia are susceptible to toxoplasmosis. A, Primary microglia and
macrophages were obtained from control and ATG7
flox/flox-Lyz-Cre mice. Atg7 and actin expression were assessed by immunoblot. Results shown are
those obtained with microglia. Similar findings were observed in primary macrophages. Microglia and macrophages were incubated with a
stimulatory anti-CD40 or control mAb, or with IFN-c/TNF-a followed by infection with tachyzoites of RH T. gondii. B–F, ATG7
flox/flox-Lyz-Cre and control
mice were infected with ME49 T. gondii. Mice (4–5 mice per group) were euthanized at 3 weeks post-infection. B, ATG7
flox/flox-Lyz-Cre mice exhibit
higher parasite load in the eye and brain than control mice. Numbers of tissue cysts were determined in 100 high power fields. C, D, Compared to
control mice (C), infected ATG7
flox/flox-Lyz-Cre mice (D) revealed more prominent disruption of retinal architecture and inflammation. PASH; X200. E, F,
Compared to control mice (E), infected ATG7
flox/flox-Lyz-Cre mice (F) show more prominent areas of inflammation (arrow) and frequent tissue cysts
(arrow head) in the brain. PASH X100. G, Eyes and brains were obtained at 3 weeks post-infection and used to isolate RNA. Levels of IFN-c, TNF-a and
NOS2 mRNA were examined using real time quantitative PCR and normalized against the levels of 18s rRNA. Each group contained 5 mice. H,
Splenocytes were obtained from control and ATG7
flox/flox-Lyz-Cre mice 3 weeks post-infection with ME49 T. gondii and were incubated with TLA as
described in Materials and Methods. The percentages of CD3
+ CD4
+ or CD3
+ CD8
+ T cells that became IFN-c
+ or IL-4
+ cells were determined by flow
cytometry. Results are shown as the mean 6 SEM and are representative of 3 independent experiments. **p#0.01.
doi:10.1371/journal.pone.0014472.g007
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autophagy promotes resistance against T. gondii. Indeed, the
studies with ATG7
flox/flox-Lyz-Cre mice provide an in vivo correlate
to our in vitro studies on autophagic killing of T. gondii in microglia/
macrophages and indicate that autophagy in those cells is likely
required for resistance against toxoplasmosis in neural tissue.
Beclin 1 plays a central role in autophagy by promoting the
formation of autophagosomes [23]. Our studies identified CD40 as
a regulator of Beclin 1 since engagement of CD40 resulted in a
rapid increase in Beclin 1 expression and enhanced autophagy.
Changes in Beclin 1 levels were functionally relevant because a
moderate increase in Beclin 1 expression markedly facilitated
CD40-induced killing of T. gondii while a moderate decrease in
Beclin 1 expression profoundly inhibited this response. Moreover,
T. gondii-infected CD40 deficient mice had lower Beclin 1 levels in
their brain microglia/macrophages and Beclin 1-deficient mice
were susceptible to cerebral and ocular toxoplasmosis. Studies in
cancer and neurodegeneration also support the relevance of Beclin
1 levels. Various cancer cells exhibit decreased Beclin 1 levels and
the anti-cancer agent tamoxifen increases expression of this
protein [25,38]. Brain injury appears to upregulate Beclin 1
[39]. In contrast, Beclin 1 is deficient in Alzheimer’s dementia and
this deficiency impairs neuronal autophagy promoting neurode-
generation [40]. In this model, lentiviral-induced overexpression of
Beclin 1 reduces amyloid b pathology [40]. Thus, upregulation of
Beclin 1 may drive not only host protection in the CNS but may
also activate autophagy as a homeostatic mechanism to reduce
cellular damage.
Beclin 1 is not only targeted by CD40-dependent adaptive
immunity to stimulate autophagy but can also be targeted by a
pathogen to impair autophagy. For example, neurovirulent HSV-
1 and HIV-1 encode an ICP34.5 protein and Nef respectively that
bind Beclin 1 and block autophagy [11,41]. The influenza M2
protein blocks autophagosome maturation, an effect that may be
mediated through interference with Beclin 1 [42]. Together, these
studies and our work indicate that Beclin 1 is an important
regulator of autophagy during host-pathogen interaction.
Our results indicate that p21 acts as a link between CD40 and
Beclin 1 upregulation and stimulation of autophagy. p21 is not
only an inhibitor of cyclin-dependent kinases but it also diminishes
expression of Beclin 1 and Atg5 [27]. C2-ceramide inhibits
autophagy in mouse embryonal fibroblasts because it triggers p21-
dependent protein degradation of Beclin 1 and Atg5 [27]. Prior
studies addressed the effects of CD40 on p21 expression in B cells.
CD40 down-regulates p21 in WEHI 231 immature B lymphoma
cells treated with anti-IgM antibody [43]. The discordant results
on the effects of CD40 on p21 expression reported in other studies
may be explained by differences in the stages of B cell
development [44]. We report that CD40 stimulation rapidly
reduced p21 protein expression in microglia. Moreover, knock-
down of p21 in microglia promoted upregulation of Beclin 1 and
autophagic killing of T. gondii in response to CD40 stimulation
while overexpression of p21 impaired the ability of CD40 to
upregulate Beclin 1 and kill T. gondii.
Mouse models of T. gondii infection are used to study immunity
against the parasite. However, these models do not fully mimic the
immune response in humans. While IFN-c is indispensable to
control the parasite in mice, mechanisms of resistance against T.
gondii that do not rely on IFN-c are likely more effective in
humans. Children with an autosomal dominant defect in IFN-cR1
that causes a deletion in the STAT1 binding site do not develop
disease when infected with T. gondii [45]. In contrast, STAT1
2/2
mice die within 1 week after infection with the parasite [46,47].
The differences between the immune response in humans and
mice also appear to apply to the downstream effectors of IFN-c,
NOS2 and IRG. NOS2 is more tightly regulated in humans than
in rodents and the production of nitric oxide appears to be weaker
in humans. Although IRGM has been reported to mediate anti-
bacterial activity in human macrophages [48], the role of IRG is
likely more restricted in humans than in mice. Mice have 23 IRG
genes among which Irgm1, Irgm3 and Irga6 are important
mediators of anti-T. gondii activity in mouse cells [30,49], whereas
IRG in humans have been reduced to IRGM and IRGC [50].
CD40 induces killing of T. gondii independently of IFN-c, STAT1,
NOS2, Irgm1, Irgm3 and Irga6 [6,8,33,51]. CD40-induced killing
of T. gondii may be an important contributor to control of T. gondii
in humans. Defects in the CD40 pathway are relevant to at least 3
groups of patients that develop ocular and/or cerebral toxoplas-
mosis: patients with X-linked Hyper IgM syndrome who lack
functional CD154 [52], newborns since neonatal CD4
+ T cells
exhibit impaired expression of CD154 [53,54] and CD40 levels
are reduced on neonatal dendritic cells [54], and HIV-1
+ patients
because they exhibit a defect in CD154 induction in their CD4
+ T
cells [55,56].
In conclusion, our studies revealed that immunity can stimulate
autophagy by upregulating autophagy proteins in a p21-depen-
dent manner, and the autophagic machinery was required for
resistance against cerebral and ocular toxoplasmosis despite the
induction of T. gondii-reactive T cells, IFN-c, TNF-a and NOS2.
These results shed new light on the spectrum of mechanisms of
host protection. Future studies should explore the possibility of
modulation of Beclin 1, autophagy and/or CD40 signaling as an
approach to improve pathogen eradication.
Materials and Methods
Ethics statement
The animal experimentation guidelines of the US Department
of Health and Human Services were followed. The study was
approved by the Institutional Animal Care and Use Committee of
Case Western Reserve University School of Medicine.
Animals and parasites
C57BL/6, CD40
2/2 and mice expressing the Cre recombinase
from within the lysozyme M locus (Lyz-Cre mice) were purchased
from Jackson Laboratories and bred at the Animal Resource
Center (Case Western Reserve University). Becn1
+/2 and
ATG7
flox/flox mice have been described [24,29]. ATG7
flox/flox mice
were bred with Lyz-Cre mice. All mice were female, on a B6
background and were 8–12 week old when used for the studies.
Each experimental group consisted of 4–8 mice. Mice were
infected i.p. with 10 cysts of ME49 strain of T. gondii (gift from Dr.
George Yap, Brown University). Tachyzoites of the RH, P (gift
from Dr. Louis Weiss, Albert Einstein College of Medicine) and
PTG strains of T. gondii as well as parasites expressing cytoplasmic
DsRed (RFP) were maintained as described [6].
Histopathology and Immunohistochemistry
Unless otherwise stated, mice were anesthetized and perfused
with PBS 4 weeks after infection. Four 5 mm sections at different
areas of the brains and eyes were stained with periodic acid Schiff
hematoxylin (PASH) stain and used to score histopathologic
changes using previously described criteria [16,17]. Tissue cysts
were counted in brain homogenates or in tissue sections as
previously described [19]. Sections were incubated with anti-
NOS2 or anti-TNF-a Ab (Millipore and Abcam respectively)
followed by incubation with secondary antibody conjugated to
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resolved using a Vectastain ABC kit (Vector Laboratories).
Real-time quantitative PCR
RNA was obtained from eyes and brains using the RNeasy kit
(QIAGEN). After treatment with DNase (Ambion), 0.5 mg of RNA
was reverse transcribed to cDNA with Super-Script III reverse
transcriptase (Invitrogen) and oligo(dT)12–18 primers. cDNA
(2.5 ml) was used as template for RT-PCR using SYBR GREEN
PCR Master Mix (Applied Biosystems) and 20 pM (each) primers
in 50 ml. Gene expression was assessed using a 7300 Real Time
PCR System (Applied Biosystems). Each cDNA sample was run in
duplicate. Samples were normalized according to the content of
18S rRNA [55]. Expression of the T. gondii B1 gene was assessed
by real-time quantitative PCR. Genomic DNA was isolated from
eyes using a DNeasy kit (QIAGEN) and subjected to real-time
PCR using SYBR GREEN PCR Master Mix. Each sample was
run in duplicate and normalized against L32. Primer sequences for
IFN-c [57], TNF-a [57], NOS2 [58], 18S rRNA [55] and T. gondii
B1 gene [59] were previously described. Primer sequences for
Beclin 1 were forward: 59-GGCCAATAAGATGGGTCTGA-39,
reverse: 59-GCTGCACACAGTCCA GAAAA– 39. Primers for
the T. gondii B1 gene have been previously described [59]. Primers
for L32 were: forward 39-TGTGCAACAAATCTTCACCG-
TGC-59;
reverse 39-GGATTGGTGACTCTGATGGCC-59.
Microglia and in vitro infection with T. gondii
Primary brain and retinal microglia as well as mouse brain
microglial cell lines BV-2 and N9 (gifts from Drs. Kalipada Pahan,
Univ. of Nebraska and Dr. Jun Tan, Univ. of South Florida
respectively) were treated overnight with a stimulatory anti-CD40
mAb (1C10; 1 or 10 mg/ml), isotype control mAb or IFN-c
(100 U/ml; PeproTech) plus TNF-a (250 pg/ml; PeproTech)
[51]. Tachyzoites of the RH or ME49 strains of T. gondii were used
to infect monolayers as described [51]. When indicated, microglia
were incubated with N
G-monomethyl-L-arginine (NMA, 100 mM;
Calbiochem) or a neutralizing mAb against mouse IFN-c (XMG
1.2; 10 mg/ml; eBiosciences) in the presence of anti-CD40 mAb,
control mAb or IFN-c/TNF-a. 3-methyl adenine (3-MA; 10 mM;
Sigma-Aldrich) was added to monolayers 1 hour after infection.
Parasite replication was assessed by light microscopy [51]. To
isolate brain mononuclear cells from infected mice, brains were
digested with papain (15 IU/ml)/DNAse (15 mg/ml; Worthington
Biochemicals) for 30 min at 37uC. Tissue was dissociated and cells
were loaded onto a gradient made with 30% and 60% isotonic
Percoll. Gradients were centrifuged at 10006g for 30 min. Cells
present in the interphase were collected and washed. Microglia/
macrophages were purified using anti-CD11b-coated magnetic
beads (Miltenyi Biotec). This resulted in populations that were
.95% F4/80
+.
Lentiviral vectors
We constructed an shRNA against mouse Atg5 using the
following oligo pair (sense and antisense strands are underlined
while the loop is italicized): forward 59-TGGATGAGATAACT-
GAAAGATTCAAGAGA TCTTTCAGTTATCTCATCCTTT-
TTTC-39; reverse 59-TCGAGAAAAAAGGATGA GATAACT-
GAAAGATCTCTTGAATCTTTCAGTTATCTCATCCA-39.A n
XhoI restriction site was included at the 59-end of the reverse oligo
to facilitate cloning. An shRNA against luciferase was used as
control [60]. Oligo pairs were annealed and subcloned into the
polylinker region of the pLL3.7 vector [61] (American Type
Tissue Collection) followed by sequence verification. To generate
lentivirus, we co-transfected pLL3.7 containing shRNA and
packaging vectors VSV-G, RSV-REV, pMDL-g/p RRE into
293T cells. Supernatants were collected at 24 and 48 h, passed
through a 0.45 mm filter, concentrated by ultracentrifugation and
stored at 280uC. Cells were transduced by incubation with
lentiviral particles at a MOI of 10:1 in the presence of polybrene
(8 mg/ml). EGFP
+ cells were sorted by FACS at 4 days post-
transduction. Efficiency of gene silencing was determined by
immunoblot.
Transfection of microglia and immunofluorescence
Using an Amaxa nucleofector as previously described [6], BV-2
cells were transfected with either control siRNA, Beclin 1 siRNA
[62], p21 siRNA [27], Irga6 siRNA [63] (all from Dharmacon),
empty vector, or plasmid that encode Beclin 1 [64], p21 [65] or
LC3-EGFP (gift from Tamotsu Yoshimori, National Institute for
Basic Biology, Okazaki, Japan). The numbers of LC3
+ punctae
were determined using a Leica DMI 6000 B automated
microscope equipped for epifluorescence microscopy. Distinct
structures that measure at least 1 mm in diameter were identified
as LC3 punctae. Experimental groups had triplicate samples and
at least 50 cells per sample were counted. Co-localization of LC3-
EGFP around RFP-T. gondii was assessed as described [6].
Immunoblot
Membranes were probed with either antibody to Atg5
(ProteinTech Group Inc), Atg7 (Cell Signaling), Beclin 1 (BD
Biosciences), p21 (Santa Cruz Biotechnologies), NOS2 (BD
Biosciences), TNF-a (Abcam Inc.), Irga6 (Santa Cruz Biotechnol-
ogies) or actin (Santa Cruz Biotechnologies), followed by
incubation with secondary Ab conjugated to horseradish perox-
idase (Santa Cruz Biotechnologies). Bands were developed using
enhanced chemiluminescence. In experiments that assessed the
effect of CD40 stimulation on Beclin 1, Atg5, Atg7 and p21
expression, microglia were pre-incubated with IFN-c for 18 h to
increase the percentage of CD40
+ cells. After extensive washing,
microglia were incubated with anti-CD40 or control mAb. Pre-
incubation with IFN-c was never used in studies of CD40-
dependent anti-microbial activity.
Flow cytometry
Cells were stained with anti-CD3, anti-CD4, anti-CD8, anti-
CD11b, anti-CD40, anti-CD45R, anti-CD49d (DX5), anti-
Ly6G (Gr-1), anti-F4/80 or isotype control mAbs (all from
eBiosciences). For detection of intracellular cytokines, spleno-
cytes were incubated with T. gondii lysate antigen (TLA; 10 mg/
ml) for 48 and 72 h. PMA (1 ng/ml; Sigma Chemical),
ionomycin (1 mg/ml; Sigma Chemical) and brefeldin A (10 mg/
ml; eBiosciences) were added during the last 5 h of incubation.
Cells were permeabilized using IntraPrep permeabilization
reagent (Coulter-Immunotech) and stained with anti-IFN-c or
anti-IL-4 mAb (eBiosciences). Cells were analyzed using an LSR
II (BD Biosciences).
Cytokine assays
CD4
+ T cells were purified from the spleens of infected
animals using magnetic beads (Miltenyi). CD4
+ T cells (1610
6/
ml) and were incubated with autologous bone marrow derived
macrophages (2.5610
5/ml) plus either TLA (10 mg/ml) or
concanavalin A (5 mg/ml; Sigma Chemical). Supernatants were
collected at 48 h. Concentrations of IFN-c in tissue culture
supernatants were determined by enzyme-linked immunosor-
bent assay (Endogen).
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Statistical significance was assessed by Student’s t test and
ANOVA. Mortality curves and histopathologic changes were
analyzed using Mann-Whitney U test. Differences were considered
statistically significant when P was ,0.05.
Supporting Information
Figure S1 CD40 induces anti-T. gondii activity in microglia
independently of IFN-c and nitric oxide. A, B, Primary brain
microglia were incubated with a stimulatory anti-CD40 or control
mAb, or with IFN-c/TNF-a as indicated followed by infection
with tachyzoites of RH T. gondii. Microglia were also treated with a
neutralizing anti-IFN-c mAb (A) or NMA (B) prior to addition of
anti-CD40 mAb or IFN-c/TNF-a. The numbers of tachyzoites
per 100 microglia were determined microscopically at 18 h post-
infection. Results are shown as the mean + SEM and are
representative of 3 independent experiments. **p,0.01.
Found at: doi:10.1371/journal.pone.0014472.s001 (0.11 MB TIF)
Figure S2 Autophagy mediates anti-T. gondii activity induced by
CD40 in microglia. A, Primary brain microglia from B6 mice were
incubated with a stimulatory anti-CD40 or control mAb, or with
IFN-c/TNF-a as indicated. 3-MA or vehicle were added 1 hour
after challenge with RH T. gondii. The numbers of tachyzoites per
100 microglia were determined microscopically at 18 hours post-
infection. B–D, Knockdown of Atg5 abrogates anti-T. gondii
activity induced by CD40 stimulation. Primary bone marrow-
derived macrophages (B), primary brain microglia (C) or BV-2
cells (D) were transduced with EGFP-encoding lentiviral vectors
that contained either shRNA against Atg5 or control shRNA.
EGFP
+ cells were sorted 4 days after transduction. Protein
expression of Atg5 and actin were examined by immunoblot.
Cells were then incubated with a stimulatory anti-CD40 mAb,
control mAb or IFN-c/TNF-a followed by infection with RH T.
gondii. The numbers of tachyzoites per 100 microglia/macrophag-
es were determined microscopically at 18 h post-infection. Results
are shown as the mean + SEM and are representative of 3
independent experiments. **p,0.01.
Found at: doi:10.1371/journal.pone.0014472.s002 (0.17 MB TIF)
Figure S3 CD40 induces anti-microbial activity against not only
type I but also type II strains of T. gondii, and this effect is
independent of Irga6. A, BV-2 cells were incubated with a
stimulatory anti-CD40 or control mAb followed by challenge with
tachyzoites of the RH strain of T. gondii (type I strain) or the P
strain (ME49 clone) of the parasite (type II strain). The numbers of
tachyzoites per 100 microglia were determined microscopically at
18 hours post-infection. B, BV-2 cells were transfected with control
siRNA or siRNA against Beclin 1. BV-2 cells transfected with
control siRNA or siRNA against Beclin 1 were incubated with a
stimulatory anti-CD40 mAb, control mAb or IFN-c/TNF-a
followed by infection with a type II strain of T. gondii (P strain). C,
BV-2 cells were transfected with control or Irga6 siRNA. Protein
expression of Irga6 and actin were examined by immunoblot.
Cells were then incubated with a stimulatory anti-CD40 mAb,
control mAb or IFN-c/TNF-a followed by infection with a type II
strain of T. gondii (P strain). Results are shown as the mean + SEM
and are representative of 3 independent experiments. **p,0.01.
Found at: doi:10.1371/journal.pone.0014472.s003 (0.15 MB TIF)
Figure S4 CD40 does not affect Beclin 1 mRNA levels. A,
Primary brain microglia from B6 mice were incubated with a
stimulatory anti-CD40 mAb or control mAb. Serial dilutions of
cDNA were used to examine levels of Beclin 1 mRNA by real-time
quantitative PCR, which were normalized against the levels of 18s
rRNA. B, Four weeks after infection with ME49 T. gondii,
microglia/macrophages were purified from brains of B6 or
CD40
2/2 mice. Beclin 1 mRNA levels were examined by real-
time PCR. Each bar represents a single mouse. Results are shown
as the mean + SEM and are representative of 3 independent
experiments.
Found at: doi:10.1371/journal.pone.0014472.s004 (0.09 MB TIF)
Figure S5 Becn1
+/2 mice do not have abnormal lymphoid
organ phenotypic composition or defective induction of T. gondii-
specific T cell response. A, Splenocytes were obtained from
uninfected control, Becn1
+/2 and CD40
2/2 mice. Expression of
CD4
+ T cells (CD3
+ CD4
+), CD8
+ T cells (CD3
+ CD8
+), B cells
(CD45R
+), NK cells (CD49d
+), and granulocytes (Ly6-G
+) were
examined by flow cytometry. B, Splenocytes were obtained from
control, Becn1
+/2 and CD40
2/2 mice 4 weeks post-infection with
ME49 T. gondii and were incubated with TLA as described in
Materials and Methods. The percentages of CD3
+ CD
4+ or CD3
+
CD8
+ T cells that became IFN-c
+ or IL-4
+ cells were determined
by flow cytometry. C, Purified CD4
+ T cells were obtained 4
weeks post-infection with ME49 T. gondii and were stimulated with
macrophages plus TLA or Concanavalin A (Con A). IFN-c
in supernatants was measured by ELISA. Results are shown as
the mean + SEM and are representative of 3 independent
experiments.
Found at: doi:10.1371/journal.pone.0014472.s005 (0.12 MB TIF)
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